Press Releases Alcon Inc.

Equities

ALC

CH0432492467

Market Closed - Swiss Exchange Other stock markets 09:01:19 06/05/2024 pm IST			5-day change	1st Jan Change
72.5 ^CHF	+0.47%		+0.95%	+10.45%

29/04	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
29/04	Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alcon Publishes Agenda for 2024 Annual General Meeting	08/04	BU
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04	AQ
Alcon : Terry Kim, MD, Joins Alcon as Chief Medical Officer and Head of Global Medical Safety	26/03	PU
Alcon : Terry Kim, MD, Joins Alcon as Chief Medical Officer and Head of Global Medical Safety	26/03	PU
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India	12/03	BU
Alcon - Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone	07/03	AQ
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone	06/03	BU
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone	06/03	BU
Alcon Loses Sight Of Dismissal In Suit Over Its Eye Drops' "30 Day Supply" Claims	04/03	AQ
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023	28/02	BU
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye	10/01	BU
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference	27/12	BU
Alcon Reports Third Quarter 2023 Results	15/11	BU
Alcon : Third Quarter 2023 Earnings Conference Call Regulatory Filing	14/11	PU
Alcon : Third Quarter 2023 Earnings Conference Call Press Release	14/11	PU
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023	30/23/30	BU
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia	10/23/10	BU
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence	09/23/09	BU
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams	07/23/07	BU
Alcon Reports Second Quarter 2023 Results	16/23/16	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ALCON : Despite the slight Q4 miss, the markets cheered the 2024 guidance

February 28, 2024 at 06:14 pm IST

ALCON : Optimum visibility for the future

May 29, 2023 at 03:38 pm IST